Industry Verticals »

All Categories

Insights »

About TMR »

U.S., Europe and Japan Orthopedic Soft Tissue Surgical Procedures Market

U.S., Europe and Japan Orthopedic Soft Tissue Surgical Procedures Market (Rotator Cuff Repair, Vaginal Prolapse, Lateral Epicondylitis, Achilles Tendinosis Repair, Gluteal Tendon/Trochanteric Bursitis Repair and Anterior Cruciate Ligament (ACL) Reconstruction): Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

Orthopedic soft tissue repair is a branch of medicine concerned with the diagnosis and treatment of damaged muscles, tendons and ligaments. Soft tissue injuries are commonly witnessed in adults, due to trauma, overuse of the tendon and recreational activities. Also, repetitive activities in sports lead to thinning of muscles over time, ultimately leading to injury. Trend of sports activities such as football, volleyball, cricket, baseball and others is increasing in the regions such as the U.S., Europe and Japan. According to the Centers for Disease Control and Prevention (CDC) there are around 2 million sports injuries, 50,000 doctor visits and 30,000 hospitalizations in the U.S. each year. Thus, high incidence of sports related injuries increase the demand for orthopedic soft tissue repair surgeries in these developed regions. Similarly, according to the United Nations, developed regions such as Europe and North America (the U.S. and Canada) have highest percentage of aged population and are expected to grow at a higher rate in the future. This population bracket which is at high risk for fractures and injuries would increase the demand for surgical intervention.
 
Likewise, growing trend of minimally invasive surgeries, increasing number of sports related association and advancements in orthopedic surgical products is also anticipated to stimulate the growth of orthopedic soft tissue surgical procedures market in the U.S, Europe and Japan. However, asymptomatic nature of soft tissue injuries such as anterior cruciate ligament rupture, achilles and lateral epicondylitis and treatment of these ruptures through conservative therapy would limit the market growth during the forecast period. 
 
The market of orthopedic soft tissue surgical procedures is categorized into surgeries such as rotator cuff repair, vaginal prolapse, lateral epicondylitis, achilles tendinosis repair, gluteal tendon and anterior cruciate ligament reconstruction. Amongst these, anterior cruciate ligament (ACL) reconstruction held the largest share of the market in 2013. It is witnessed that approximately more than 30% of the cases reported with ACL ruptures require surgical intervention. Thus, high rate of ACL surgical intervention coupled with high cost of the treatment are estimated as the key reasons for the dominance of this market segment. Rotator cuff repair market is expected to grow at a moderate CAGR in the future due to rising number of rotator cuff injuries and introduction of effective bioabsorbable products.
 
Based on geography, the orthopedic soft tissue surgical procedures market is divided into the U.S., Europe and Japan. The U.S. market for the orthopedic soft tissue surgeries is estimated as the largest market in terms of revenues and is also forecasted to retain its leadership position in the future. Increasing obesity and aging population coupled with rising sport related injuries contributed towards the leadership position of this market in the U.S. The Europe orthopedic soft tissue repair market is anticipated to witness slow growth rate owing to economic downturn and cost containment and lower out-of-pocket spending. Additionally, reduction in budget allocation by governments in Europe towards sports activities would also limit the market growth to a certain extent. For instance, the Federation of Irish Sports announced a reduction of around 7% in core sports funding in 2013.
 
Arthrex, Inc., Smith & Nephew plc, ArthroCare Corporation, DePuy Synthes, Inc., Biomet, Inc., Stryker Corporation, CONMED Corporation and others are some of the prominent players operating in orthopedic soft tissue repair market.
 
     
    Chapter 1 Introduction
    1.1 Report Description
    1.2 Market Segmentation
    1.3 Research Methodology
          1.3.1 Sources
                  1.3.1.1 Secondary Research
                  1.3.1.2 Primary Research
          1.3.2 Assumptions
     
    Chapter 2 Executive Summary
    2.1 Market Snapshot: Orthopedic Soft Tissue Surgical Procedures Market (2013 & 2020)
    2.2 Orthopedic Soft Tissue Surgical Procedures Market, by Geography, 2013 (USD Million)
     
    Chapter 3 Orthopedic Soft Tissue Surgical Procedures Market Overview
    3.1 Overview
          3.1.1 Orthopedic Soft Tissue Surgical Procedures Market Revenue, by Geography, 2012 – 2020 (USD Million)
    3.2 Market Dynamics
          3.2.1 Market Drivers
                  3.2.1.1 Aging population coupled with growing participation in sports activities boost market growth
                  3.2.1.2 Increasing number of sports medicine associations would promote market growth
                  3.2.1.3 Growing trend of minimally invasive procedures promotes market expansion
                  3.2.1.4 Advancements in orthopedic surgical products drive demand for soft tissue surgeries, thereby boosting market growth
          3.2.2 Market Restraints
                  3.2.2.1 Asymptomatic nature of orthopedic injuries and availability of non-operative treatments restrains growth
                  3.2.2.2 High cost of surgeries and rising trend of medical tourism hampers market growth
          3.2.3 Opportunities
                  3.2.3.1 Strong research and development activities to develop novel orthopedic surgical products provides good platform to record high growth
    3.3 Porter’s Five Force Analysis: Orthopedic Soft Tissue Surgical Procedures Market, by Products
          3.3.1 Bargaining power of suppliers
          3.3.2 Bargaining power of buyers
          3.3.3 Threat of new entrants
          3.3.4 Threat of substitutes
          3.3.5 Competitive rivalry
    3.4 Event Impact Analysis
    3.5 Regulatory Scenario
          3.5.1 U.S.
                  3.5.1.1 Major Steps: U.S. FDA Regulatory Approval Pathway
          3.5.2 Europe
                  3.5.2.1 Major Steps: CE Marking Regulatory Approval Pathway
          3.5.3 Japan
    3.6 Market Attractiveness Analysis: Orthopedic Soft Tissue Surgical Procedures Market, by Geography
    3.7 Competitive Landscape
          3.7.1 U.S., Europe, and Japan Orthopedic Soft Tissue Surgical Procedures Market Share Analysis, by Key Players, 2013 (%)
     
    Chapter 4 U.S. Orthopedic Soft Tissue Surgical Procedures Market, by Indications
    4.1 Overview
          4.1.1 U.S. Orthopedic Soft Tissue Surgical Procedures Market Revenue, by Indications, 2012 – 2020 (USD Million)
    4.2 Rotator Cuff Repair
          4.2.1 U.S. Rotator Cuff Repair Market Revenue, 2012 – 2020 (USD Million)
    4.3 Vaginal Prolapse
          4.3.1 U.S. Vaginal Prolapse Market Revenue, 2012 – 2020 (USD Million)
    4.4 Lateral Epicondylitis
          4.4.1 U.S. Lateral Epicondylitis Market Revenue, 2012 – 2020 (USD Million)
    4.5 Achilles Tendinosis Repair
          4.5.1 U.S. Achilles Tendinosis Repair Market Revenue, 2012 – 2020 (USD Million)
    4.6 Gluteal Tendon/Trochanteric Bursitis Repair
          4.6.1 U.S. Gluteal Tendon Repair Market Revenue, 2012 – 2020 (USD Million)
    4.7 Anterior Cruciate Ligament (ACL) Reconstruction
          4.7.1 U.S. ACL Reconstruction Market Revenue, 2012 – 2020 (USD Million)
     
    Chapter 5 Europe Orthopedic Soft Tissue Surgical Procedures Market, by Indications
    5.1 Overview
          5.1.1 Europe Orthopedic Soft Tissue Surgical Procedures Market Revenue, by Indications, 2012 – 2020 (USD Million)
    5.2 Rotator Cuff Repair
          5.2.1 Europe Rotator Cuff Repair Market Revenue, 2012 – 2020 (USD Million)
    5.3 Vaginal Prolapse
          5.3.1 Europe Vaginal Prolapse Market Revenue, 2012 – 2020 (USD Million)
    5.4 Lateral Epicondylitis
          5.4.1 Europe Lateral Epicondylitis Market Revenue, 2012 – 2020 (USD Million)
    5.5 Achilles Tendinosis Repair
          5.5.1 Europe Achilles Tendinosis Repair Market Revenue, 2012 – 2020 (USD Million)
    5.6 Gluteal Tendon / Trochanteric Bursitis Repair
          5.6.1 Europe Gluteal Tendon Repair Market Revenue, 2012 – 2020 (USD Million)
    5.7 Anterior Cruciate Ligament (ACL) Reconstruction
          5.7.1 Europe Anterior Cruciate Ligament Reconstruction Market Revenue, 2012 – 2020 (USD Million)
     
    Chapter 6 Japan Orthopedic Soft Tissue Surgical Procedures Market, by Indications
    6.1 Overview
          6.1.1 Japan Orthopedic Soft Tissue Surgical Procedures Market Revenue, by Indications, 2012 – 2020 (USD Million)
    6.2 Rotator Cuff Repair
          6.2.1 Japan Rotator Cuff Repair Market Revenue , 2012 – 2020 (USD Million)
    6.3 Vaginal Prolapse
          6.3.1 Japan Vaginal Prolapse Market Revenue , 2012 – 2020 (USD Million)
    6.4 Lateral Epicondylitis
          6.4.1 Japan Lateral Epicondylitis Market Revenue , 2012 – 2020 (USD Million)
    6.5 Achilles Tendinosis Repair
          6.5.1 Japan Achilles Tendinosis Repair Market Revenue , 2012 – 2020 (USD Million)
    6.6 Gluteal Tendon / Trochanteric Bursitis Repair
          6.6.1 Japan Gluteal Tendon Market Revenue , 2012 – 2020 (USD Million)
    6.7 Anterior Cruciate Ligament (ACL) Reconstruction
          6.7.1 Japan ACL Reconstruction Market Revenue , 2012 – 2020 (USD Million)
     
    Chapter 7 Recommendations
    7.1 Market Strategy for Success
          7.1.1 Strategic alliance, mergers and acquisitions offer a strong platform for companies to expand their geographic presence
          7.1.2 Organize marketing campaigns that highlight the cost benefits and clinical advantages of the products and orthopedic surgeries
          7.1.3 Long-term contracts with health care service providers and orthopedic surgeons
     
    Chapter 8 Company Profiles
    8.1 Arthrex, Inc.
          8.1.1 Company Overview
          8.1.2 Financial Overview
          8.1.3 Product Portfolio
          8.1.4 Business Strategies
          8.1.5 Recent Developments
    8.2 ArthroCare Corporation
          8.2.1 Company Profile
          8.2.2 Financial Overview
          8.2.3 Product Portfolio
          8.2.4 Business Strategies
          8.2.5 Recent Developments
    8.3 Biomet, Inc.
          8.3.1 Company Overview
          8.3.2 Financial Overview
          8.3.3 Product Portfolio
          8.3.4 Business Strategies
          8.3.5 Recent Development
    8.4 CONMED Corporation
          8.4.1 Company Overview
          8.4.2 Financial Overview
          8.4.3 Product Portfolio
          8.4.4 Business Strategies
          8.4.5 Recent Developments
    8.5 DePuy Synthes, Inc.
          8.5.1 Company Overview
          8.5.2 Financial Overview
          8.5.3 Product Portfolio
          8.5.4 Business Strategies
          8.5.5 Recent Developments
    8.6 Smith & Nephew plc
          8.6.1 Company Overview
          8.6.2 Financial Overview
          8.6.3 Product Portfolio
          8.6.4 Business Strategies
          8.6.5 Recent Developments
    8.7 Stryker Corporation
          8.7.1 Company Overview
          8.7.2 Financial Overview
          8.7.3 Product Portfolio
          8.7.4 Business Strategies
          8.7.5 Recent Developments
    List of Tables
     
    TABLE 1 Market Snapshot: Orthopedic Soft Tissue Surgical Procedures Market (2013 & 2020)
    TABLE 2 Orthopedic Soft Tissue Surgical Procedures Market Revenue, by Geography, 2012 – 2020 (USD Million)
    TABLE 3 Impact Analysis of Market Drivers
    TABLE 4 Impact Analysis of Market Restraints
    TABLE 5 U.S. Orthopedic Soft Tissue Surgical Procedures Market Revenue, by Indications, 2012 – 2020 (USD Million)
    TABLE 6 Europe Orthopedic Soft Tissue Surgical Procedures Market Revenue, by Indications, 2012 – 2020 (USD Million)
    TABLE 7 Japan Orthopedic Soft Tissue Surgical Procedures Market Revenue, by Indications, 2012 – 2020 (USD Million)

    List of Figures

     

    FIG. 1 Orthopedic Soft Tissue Surgical Procedures: Market Segmentation

    FIG. 2 Orthopedic Soft Tissue Surgical Procedures Market, by Geography, 2013 (USD Million)

    FIG. 3 Porter’s Five Forces Analysis: Orthopedic Soft Tissue Surgical Procedures Market, by Products

    FIG. 4 Major Steps: U.S. FDA Regulatory Approval Pathway

    FIG. 5 Major Steps: CE Marking Regulatory Approval Pathway

    FIG. 6 Market Attractiveness Analysis: Orthopedic Soft Tissue Surgical Procedures Market, by Geography

    FIG. 7 U.S., Europe and Japan Orthopedic Soft Tissue Surgical Procedures: Market Share, by Key Players, 2013 (%)

    FIG. 8 U.S. Rotator Cuff Repair Market Revenue, 2012 - 2020 (USD Million)

    FIG. 9 U.S. Vaginal Prolapse Market Revenue, 2012 - 2020 (USD Million)

    FIG. 10 U.S. Lateral Epicondylitis Market Revenue, 2012 - 2020 (USD Million)

    FIG. 11 U.S. Achilles Tendinosis Repair Market Revenue, 2012 - 2020 (USD Million)

    FIG. 12 U.S. Gluteal Tendon Repair Market Revenue, 2012 - 2020 (USD Million)

    FIG. 13 U.S. ACL Reconstruction Market Revenue, 2012 - 2020 (USD Million)

    FIG. 14 Europe Rotator Cuff Repair Market Revenue, 2012 - 2020 (USD Million)

    FIG. 15 Europe Vaginal Prolapse Market Revenue, 2012 - 2020 (USD Million)

    FIG. 16 Europe Lateral Epicondylitis Market Revenue, 2012 - 2020 (USD Million)

    FIG. 17 Europe Achilles Tendinosis Repair Market Revenue, 2012 - 2020 (USD Million)

    FIG. 18 Europe Gluteal Tendon Repair Market Revenue, 2012 - 2020 (USD Million)

    FIG. 19 Europe Anterior Cruciate Ligament Reconstruction Market Revenue, 2012 - 2020 (USD Million)

    FIG. 20 Japan Rotator Cuff Repair Market Revenue, 2012 - 2020 (USD Million)

    FIG. 21 Japan Vaginal Prolapse Market Revenue, 2012 - 2020 (USD Million)

    FIG. 22 Japan Lateral Epicondylitis Market Revenue, 2012 - 2020 (USD Million)

    FIG. 23 Japan Achilles Tendinosis Repair Market Revenue, 2012 - 2020 (USD Million)

    FIG. 24 Japan Gluteal Tendon Market Revenue, 2012 - 2020 (USD Million)

    FIG. 25 Japan ACL Reconstruction Market Revenue, 2012 - 2020 (USD Million)

    FIG. 26 ArthroCare Corporation, Annual Revenue: 2011 – 2013 (USD Million)

    FIG. 27 CONMED Corporation: Annual Revenue, 2011 – 2013 (USD Million)

    FIG. 28 Johnson & Johnson, Orthopedic Franchise**, Annual Revenue: 2011 – 2013 (USD Million)

    FIG. 29 Smith & Nephew plc: Annual Revenue, 2011 – 2013 (USD Million)

    FIG. 30 Stryker Corporation, Annual Revenue, 2011 – 2013 (USD Million) 

Copyright © Transparency Market Research, Inc. All Rights reserved

U.S., Europe and Japan Orthopedic Soft Tissue Surgical Procedures Market

Schedule a Call